As part of the Trump Administration’s commitment to transform American health care and rebuild trust in public health, the U.S. Food and Drug Administration’s Commissioner Martin A. Makary, M.D., M.P.H., will lead a roundtable discussion of an independent panel of scientific experts to discuss the safety and necessity of talc as an additive in food, drug, and cosmetic products. This public roundtable, taking place on Tuesday, May 20, 2025 at 10 a.m. ET, will follow a transparent process grounded in gold standard science, setting precedents for future discussions.
The group, comprised of world-renowned experts in their respective fields, will review the latest scientific evidence, evaluate potential health risks, explore safer alternatives, and individual experts may offer their recommendations for regulatory action. Unlike under the previous administration, members of the media and public are welcome and encouraged to attend and listen to the discussion.
Talc, a naturally occurring mineral used in a variety of consumer products, has come under increased scrutiny due to concerns about potential health effects, especially when contaminated with asbestos or consumed over prolonged periods. The panel will review data related to talc exposure and evaluate its continued use within the context of public health needs and available alternatives.
“Despite the potential carcinogenic harm with topical talc, it continues to be ingested by children and adults through food and some medications. We are bringing together a group of leading independent experts to assess the available evidence around talc and consider whether its continued use is necessary given modern alternatives,” said FDA Commissioner Martin A. Makary, M.D., M.P.H. “This is a critical step toward ensuring that ingredients in products used every day by Americans meet the highest standards for safety.”
